Industry Reports

Irish drugmaker Shire has signed a merger agreement to acquire US-based NPS Pharmaceuticals for $5.2bn. As part of the deal, Shire will acquire NPS Pharma's outstanding shares for $46 per share in cash. The transaction was...

US-based drug maker Pfizer has completed the acquisition of marketed vaccines portfolio from Baxter International for $635m. As part of the deal, Pfizer also acquired a portion of Baxter's facility in Orth, Austria, where these vaccines...

US-based Johnson & Johnson (J&J) has completed the acquisition of a privately held clinical stage biopharmaceutical company, AliosBioPharma, for $1.75bn in cash. Based in California, US, AliosBioPharma develops therapies for the treatment of viral diseases. The...

Aegerion Pharmaceuticals has signed an agreement to acquire an orphan product Myalept (metreleptin for injection) from AstraZeneca. AstraZeneca will receive $325m upfront payment to divest the rights to develop, manufacture and commercialise Myalept, subject to an...

Sales of $19.5 Billion increased 9.1% Versus 2013 Second Quarter; Second-Quarter EPS was $1.51 Excluding Special Items, 2014 Second-Quarter EPS of $1.66 increased 12.2%* Johnson & Johnson today announced sales of $19.5 billion for the second...

Pivotal Therapeutics Inc. , a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its operational highlights and financial results for the three months ended March 31, 2014.  All dollar amounts referenced...

China Nepstar Chain Drugstore Ltd., a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the first quarter ended March 31, 2014. Financial Highlights...